Low Dose Naltrexone Resources

Our accreditations place us in the top 1% of compounding pharmacies
John Herr, PCCA Advisory Council, Owner of Town & Country Compounding Pharmacy

Low Dose Naltrexone (LDN) expert John Herr, RPh.

Expert Pharmacist John Herr, RPh. has worked with researchers, physicians, and patients worldwide to become an expert in proper titrations & dosage of Low Dose Naltrexone (LDN).

He has observed its multiple benefits for chronic pain & various autoimmune conditions.

Sending prescriptions to
Town & Country Compounding

It’s easy for licensed practitioners to prescribe medications for patients using Town & Country Compounding. 

For Prescribers

LDN Video From a Pain Management Specialist.
Low Dose Naltrexone (LDN) Resources
Featured LDN Review Article: The Use of Low-Dose Naltrexone (LDN) as a Novel Anti-Inflammatory Treatment for Chronic Pain

Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and complex regional pain syndrome. We review the evidence that LDN may operate as a novel anti-inflammatory agent in the central nervous system, via action on microglial cells.

This review covers the typical usage of LDN in clinical trials, caveats to using the medication, and recommendations for future research and clinical work. LDN may represent one of the first glial cell modulators to be used for the management of chronic pain disorders.


*Younger, J., Parkitny, L., & Mclain, D. (2014). The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clinical Rheumatology, 33(4), 451-459. doi:10.1007/s10067-014-2517-2

Dr. Asher Goldstein
Board Certified Physician Specializing in Pain Management and Opioid Detox

Learn About LDN From an Experienced Physician

Get insight from providers that prescribe Low Dose Naltrexone (LDN) for their patients.

Low Dose Naltrexone (LDN) Presentation/Pain Management and Immune Dysfunction Diseases

(43 minutes)

Blogs on Low Dose Naltrexone (LDN)